We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

206 hedge funds and large institutions have $64.8M invested in Editas Medicine in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 61 increasing their positions, 57 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 57

2% more call options, than puts

Call options by funds: $396K | Put options by funds: $388K

5.01% less ownership

Funds ownership: 66.86% → 61.84% (-5%)

10% less funds holding

Funds holding: 229 → 206 (-23)

33% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 58

65% less capital invested

Capital invested by funds: $188M → $64.8M (-$123M)

Holders
206
Holders Change
-23
Holders Change %
-10.04%
% of All Funds
2.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
61
Reduced
57
Closed
58
Calls
$396K
Puts
$388K
Net Calls
+$8K
Net Calls Change
-$354K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$3.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.87M
3
MAM
Monaco Asset Management
Monaco
+$2.73M
4
UBS Group
UBS Group
Switzerland
+$1.79M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$1.77M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$16.7M
2
APM
Avidity Partners Management
Texas
-$5M
3
Pictet Asset Management
Pictet Asset Management
Switzerland
-$4.02M
4
BlackRock
BlackRock
New York
-$1.83M
5
Millennium Management
Millennium Management
New York
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
151
Steward Partners Investment Advisory
New York
$667 +$255 +100 +24%
TWC
152
TD Waterhouse Canada
Ontario, Canada
$635 -$838 -329 -40%
FDCDDQ
153
Federation des caisses Desjardins du Quebec
Quebec, Canada
$635 -$127 -50 -9%
AWM
154
Ameliora Wealth Management
Switzerland
$635 – – –
HCM
155
Hollencrest Capital Management
California
$635 – – –
SC
156
SouthState Corp
Florida
$635 – – –
AWM
157
AllSquare Wealth Management
New York
$603 -$382 -150 -24%
WT
158
Washington Trust
Rhode Island
$561 – – –
Optiver Holding
159
Optiver Holding
Netherlands
$457 +$917 +360 New
TWD
160
True Wealth Design
Ohio
$436 +$568 +223 +186%
AF
161
Allworth Financial
California
$433 -$1.29K -508 -61%
WT
162
Whittier Trust
California
$396 -$20 -8 -2%
ICM
163
Islay Capital Management
Texas
$381 – – –
NFSG
164
Newbridge Financial Services Group
Florida
$381 – – –
OCM
165
Orion Capital Management
California
$381 +$764 +300 New
CIAM
166
Caitong International Asset Management
Hong Kong
$363 +$729 +286 New
PS
167
Principal Securities
Iowa
$311 – – –
LFG
168
Larson Financial Group
Missouri
$310 – – –
FFA
169
Farther Finance Advisors
California
$287 +$576 +226 New
HPC
170
HM Payson & Co
Maine
$267 – – –
TSMHT
171
Thurston Springer Miller Herd & Titak
Indiana
$260 – – –
RP
172
Raelipskie Partnership
Ontario, Canada
$254 – – –
AWM
173
Avior Wealth Management
Nebraska
$241 +$484 +190 New
AG
174
AmeriFlex Group
Nevada
$197 +$382 +150 New
AF
175
Advisornet Financial
Minnesota
$191 -$1.03K -405 -73%
5 6
7
8 9

EDIT Hedge Fund Activity: Q4 2024 in Review

206 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2024, worth a combined $64.8M — down 65% from $188M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of EDIT and 39 opened new positions — a net loss of 19 holders — while 57 trimmed existing stakes and 61 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $3.7M. The largest seller was Deep Track Capital, exiting entirely with an estimated $16.7M sold.

  • 206 institutional investors held Editas Medicine (EDIT) as of Q4 2024, down from 229 in Q3 2024.
  • Funds reported $64.8M of Editas Medicine stock for Q4 2024, down 65% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q4 2024 and 58 closed out, a net change of -19 holders.
  • The largest Editas Medicine buyer in Q4 2024 was Renaissance Technologies, an estimated $3.7M added.
  • The largest Editas Medicine seller in Q4 2024 was Deep Track Capital, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2024.